![](/img/cover-not-exists.png)
PRO57 COST MINIMIZATION ANALYSIS OF EMICIZUMAB IN THE PROPHYLAXIS OF INHIBITOR-NEGATIVE PATIENTS WITH HEMOPHILIA A IN TURKEY
Guler, B., Oksuz, E., Malhan, S., Yanik, L., Koc, E.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.2387
Date:
November, 2019
File:
PDF, 386 KB
2019